I

ImaginAb

29 employees

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biomarker
89Zr-
Immunocology
PET radiopharmaceuticals
Oncology
Minibody
Personalized medicine
T cells
CD8 Tracer
Clinical Trials
Health Diagnostics
Antibody engineering and imaging
Health Care
Therapeutic management
Immunology
Clinical development
CD8
cancer
PET Imaging

Date founded

2007

Funding rounds raised

Total raised

$21M

from 6 investors over 6 rounds

I

ImaginAb raised $13M on June 3, 2021

Investors: Adage Capital Management

I

ImaginAb raised $8M on September 14, 2017

Investors: Adage Capital Management, Parker Institute for Cancer Immunotherapy and Nextech Invest

I

ImaginAb raised $21M on May 8, 2014

Investors: Nextech Invest

I

ImaginAb raised $13M on March 27, 2012

Investors: Momentum Bioscience Ltd

FAQ